FrancophonIA/ELRC3.0 huggingface dataset:
English: Anagrelide Mylan 0.5 mg hard capsules anagrelide
Croatian: Anagrelid Mylan 0,5 mg tvrde kapsule anagrelid
English: STATEMENT OF ACTIVE SUBSTANCE Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 0.5 mg anagrelide.
Croatian: NAVOĐENJE DJELATNE TVARI Jedna tvrda kapsula sadrži 0,5 mg anagrelida (u obliku anagrelidklorid hidrata).
English: STATEMENT OF ACTIVE SUBSTANCE Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 1 mg anagrelide.
Croatian: NAVOĐENJE DJELATNE TVARI Jedna tvrda kapsula sadrži 1 mg anagrelida (u obliku anagrelidklorid hidrata).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/17/1256/002
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/17/1256/002
English: NAME OF THE MEDICINAL PRODUCT Anagrelide Mylan 0.5 mg hard capsules Anagrelide Mylan 1 mg hard capsules
Croatian: Anagrelid Mylan 0,5 mg tvrde kapsule Anagrelid Mylan 1 mg tvrde kapsule
English: Hepatic enzymes increased
Croatian: Poremećaji jetre i žuči povećani jetreni enzimi hepatitis
English: Anagrelide Mylan 1 mg hard capsules anagrelide
Croatian: Anagrelid Mylan 1 mg tvrde kapsule anagrelid
English: Anagrelide 1 mg hard capsules
Croatian: Anagrelid 1 mg tvrde kapsule
English: Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 0.5 mg anagrelide.
Croatian: Jedna tvrda kapsula sadrži 0,5 mg anagrelida (u obliku anagrelidklorid hidrata).
English: Lactose
Croatian: Trombociti
English: Headache Dizziness
Croatian: Učestalosti nuspojava
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava anemija pancitopenija, trombocitopenija, hemoragija, ekhimoza
English: especially in the skin, abnormal feeling or sensation such as tingling and ‘pins and needles', sleeplessness, depression, confusion, nervousness, dry mouth, loss of memory, breathlessness, nosebleed, serious lung infection with fever, shortness of breath, cough, phlegm; hair loss, skin itching or discolouration, impotence, chest pain, reduction in blood platelets, which increases the risk of bleeding or bruising (thrombocytopenia), accumulation of fluid around the lungs or an increase in liver enzymes.
Croatian: Manje česte nuspojave: mogu se javiti u do 1 na 100 osoba Osjećaj slabosti ili osjećaj da Vam nije dobro, visoki krvni tlak, nepravilni otkucaji srca, nesvjestica, zimica ili vrućica, probavne smetnje, gubitak apetita, zatvor stolice, modrice, krvarenje, oticanje (edem), gubitak težine, bolovi u mišićima, bolni zglobovi, bol u leđima, smanjenje ili gubitak osjeta ili osjećaj kao što je utrnulost osobito kože, neprirodan osjećaj ili osjećaj bockanja i trnci, nesanica, depresija, smetenost, nervoza, suha usta, gubitak pamćenja, nedostatak zraka, krvarenje iz nosa, ozbiljna infekcija pluća s vrućicom, nedostatkom zraka, kašljanjem, sluzi, gubitak kose, svrbež kože ili promjena boje kože, impotencija, bol u prsnom košu, smanjenje broja krvnih pločica što povećava opasnost od krvarenja ili nastanka modrica (trombocitopenija), nakupljanje tekućine oko pluća ili porast vrijednosti jetrenih enzima.
English: Each hard capsule contains anagrelide hydrochloride monohydrate equivalent to 1 mg anagrelide.
Croatian: Jedna tvrda kapsula sadrži 1 mg anagrelida (u obliku anagrelidklorid hidrata).
English: Pulmonary hypertension Pneumonia Pleural effusion Dyspnoea Epistaxis
Croatian: Poremećaji bubrega i mokraćnog sustava impotencija zatajenje bubrega, nokturija tubulointersticij ski nefritis
English: 4.7 Effects on ability to drive and use machines In clinical development, dizziness was commonly reported.
Croatian: 4.7 Utjecaj na sposobnost upravljanja vozilima i rada sa strojevima
English: Nausea Flatulence
Croatian: Prijavljivanje nuspojava
English: Breast-feeding
Croatian: Saint-Priest
English: Interstitial lung disease including pneumonitis and allergic alveolitis
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja plućna hipertenzija, pneumonija, pleuralni izljev, dispneja, epistaksa plućni infiltrati intersticijska bolest pluća, uključujući pneumonitis i alergijski alveol itis
English: Patients should be evaluated for signs and symptoms of underlying cardiopulmonary disease prior to initiating and during anagrelide therapy.
Croatian: Prije početka te tijekom terapije anagrelidom, potrebno je procijeniti imaju li bolesnici znakove i simptome osnovne kardiopulmonalne bolesti.
English: This summary was last updated in 07-2015.
Croatian: Ovaj sažetak je posljednji put ažuriran u 07.2015.
English: Irbesartan/Hydrochlorothiazide Teva EMA/477286/2015
Croatian: Irbesartan/Hidroklorotiazid Teva EMA/477286/2015
English: It works by increasing urine output, reducing the amount of fluid in the blood and lowering the blood pressure.
Croatian: Djeluje povećavajući količinu izbačenog urina, smanjujući količinu tekućine u krvi i snižavajući krvni tlak.
English: The combination of the two active substances has an additive effect, reducing the blood pressure more than either medicine alone.
Croatian: Kombinacija dviju djelatnih tvari ima kumulativno djelovanje, snižavajući krvni tlak više nego samo jedan lijek samostalno.
English: It is available as tablets (150 mg or 300 mg irbesartan and 12.5 mg hydrochlorothiazide; and 300 mg irbesartan and 25 mg hydrochlorothiazide).
Croatian: Dostupan je u obliku tableta (150 mg ili 300 mg irbesartana i 12,5 mg hidroklorotiazida; 300 mg irbesartana i 25 mg hidroklorotiazida).
English: Doses higher than 300 mg irbesartan and 25 mg hydrochlorothiazide once a day are not recommended.
Croatian: Ne preporučuju se doze veće od 300 mg irbesartana i 25 mg hidroklorida jednom dnevno.
English: By blocking the receptors to which angiotensin II normally attaches, irbesartan stops the hormone having an effect, allowing the blood vessels to widen.
Croatian: Blokiranjem receptora na koje se angiotenzin II inače vezuje, irbesartan sprječava učinak hormona te tako omogućuje širenje krvnih žila.
English: This means that Irbesartan/Hydrochlorothiazide Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called CoAprovel.
Croatian: To znači da je lijek Irbesartan/Hidroklorotiazid Teva sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom CoAprovel.
English: Therefore, the CHMP's view was that, as for CoAprovel, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a da u pogledu lijeka CoAprovel koristi nadmašuju utvrđene rizike.
English: Irbesartan is an ‘angiotensin II receptor antagonist', which means that it blocks the action of a hormone in the body called angiotensin II.
Croatian: Irbesartan je „antagonist receptora angiotenzina II”, što znači da blokira djelovanje hormona angiotenzina II u tijelu.
English: The full EPAR for Irbesartan/Hydrochlorothiazide Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Teva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Irbesartan/Hydrochlorothiazide Teva.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Irbesartan/Hidroklorotiazid Teva.
English: For more information about treatment with Irbesartan/Hydrochlorothiazide Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Irbesartan/Hidroklorotiazid Teva pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Hydrochlorothiazide is a diuretic, which is another type of treatment for hypertension.
Croatian: Hidroklorotiazid je diuretik te predstavlja drugu vrstu liječenja hipertenzije.
English: Irbesartan/Hydrochlorothiazide Teva may be added to other treatments for hypertension.
Croatian: Irbesartan/Hidroklorotiazid Teva mogu se dodati drugim terapijama za hipertenziju.
English: The dose of Irbesartan/Hydrochlorothiazide Teva to be used depends on the dose of irbesartan or hydrochlorothiazide that the patient was taking
Croatian: Doza lijeka Irbesartan/Hidroklorotiazid Teva koju treba primjenjivati ovisi o dozama irbesartana ili hidroklorotiazida koje je bolesnik prethodno uzimao.
English: Irbesartan/Hydrochlorothiazide Teva is a ‘generic medicine'.
Croatian: Irbesartan/Hidroklorotiazid Teva „generički je lijek”.
English: This is a summary of the European public assessment report (EPAR) for Irbesartan/Hydrochlorothiazide Teva.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Irbesartan/Hidroklorotiazid Teva.
English: The CHMP concluded that, in accordance with EU requirements, Irbesartan/Hydrochlorothiazide Teva has been shown to have comparable quality and to be bioequivalent to CoAprovel.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji odlučio je kako u skladu sa zahtjevima EU-a lijek Irbesartan/Hidroklorotiazid Teva posjeduje usporedivu razinu kvalitete kao i lijek CoAprovel te je bioekvivalentan s njime.
English: The European Commission granted a marketing authorisation valid throughout the EU for Irbesartan/Hydrochlorothiazide Teva on 26 November 2009.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Irbesartan/Hidroklorotiazid Teva na snazi u Europskoj uniji od 26. studenog 2009. Cjeloviti EPAR za lijek Irbesartan/Hidroklorotiazid
English: What are the benefits and risks of Irbesartan/Hydrochlorothiazide Teva?
Croatian: Koje su koristi i rizici povezani s lijekom Irbesartan/Hidroklorotiazid Teva?
English: Irbesartan/Hydrochlorothiazide Teva is used in adults who have essential hypertension (high blood pressure) that is not adequately controlled by irbesartan or hydrochlorothiazide alone.
Croatian: Teva se koristi kod odraslih bolesnika s esencijalnom hipertenzijom (visokim krvnim tlakom) koja se ne može na odgovarajući način kontrolirati samo irbesartanom ili hidroklorotiazidom. „Esencijalna” znači da ne postoji očiti uzrok hipertenzije.
English: Because Irbesartan/Hydrochlorothiazide Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Teva generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
English: Irbesartan/Hydrochlorothiazide Teva contains two active substances, irbesartan and hydrochlorothiazide.
Croatian: Irbesartan/Hidroklorotiazid Teva sadrži dvije djelatne tvari, irbesartan i hidroklorotiazid.
English: Other information about Irbesartan/Hydrochlorothiazide Teva
Croatian: Ostale informacije o lijeku Irbesartan/Hidroklorotiazid Teva
English: Irbesartan/Hydrochlorothiazide Teva irbesartan and hydrochlorothiazide
Croatian: Irbesartan/Hidroklorotiazid Teva irbesartan i hidroklorotiazid
English: The Committee recommended that Irbesartan/Hydrochlorothiazide Teva be given marketing authorisation.
Croatian: Odbor je preporučio izdavanje odobrenja za stavljanje u promet lijeka Irbesartan/Hidroklorotiazid Teva.
English: Why has Irbesartan/Hydrochlorothiazide Teva been approved?
Croatian: Zašto je lijek Irbesartan/Hidroklorotiazid Teva odobren?
English: Because Irbesartan/Hydrochlorothiazide Teva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, CoAprovel.
Croatian: Teva generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje je li lijek bioekvivalentan referentnom lijeku CoAprovel.
English: Irbesartan/Hydrochlorothiazide Teva is taken by mouth.
Croatian: Irbesartan/Hidroklorotiazid Teva uzima se peroralno.
English: What is Irbesartan/Hydrochlorothiazide Teva?
Croatian: Što je lijek Irbesartan/Hidroklorotiazid Teva?
English: What is Irbesartan/Hydrochlorothiazide Teva used for?
Croatian: Za što se Irbesartan/Hidroklorotiazid Teva koristi?
English: How does Irbesartan/Hydrochlorothiazide Teva work?
Croatian: Kako djeluje Irbesartan/Hidroklorotiazid Teva?
English: How has Irbesartan/Hydrochlorothiazide Teva been studied?
Croatian: Kako je lijek Irbesartan/Hidroklorotiazid Teva ispitivan?
English: How is Irbesartan/Hydrochlorothiazide Teva used?
Croatian: Kako se Irbesartan/Hidroklorotiazid Teva koristi?
English: taken twice a day.
Croatian: dvaput dnevno.
English: In many of these cases, no adverse events were reported.
Croatian: U mnogima od tih slučajeva nisu zabilježeni štetni događaji.
English: Add the rest of the water.
Croatian: Dodajte preostalu vodu.
English: Your baby may be affected by one or more of these.
Croatian: Vaše dijete može imati jednu ili više takvih mana.
English: If you need to do it yourself, follow the steps below:
Croatian: Ako ga morate pripremiti sami, slijedite korake u nastavku:
English: Capsules, hard.
Croatian: Kapsule, tvrde.
English: These patients should also be carefully observed.
Croatian: Takve bolesnike potrebno je pažljivo nadzirati.
English: The educational materials shall contain the following key elements:
Croatian: Edukacijski materijali moraju sadržavati sljedeće ključne elemente:
English: A detailed description of the preparation is given below:
Croatian: Niže je naveden detaljan opis pripreme:
English: CellCept with food and drink
Croatian: CellCept s hranom i pićem
English: Allow it to dry in the air before using it again.
Croatian: Pustite da se osuši na zraku prije iduće uporabe.
English: Date of latest renewal: 13 March 2006
Croatian: Datum posljednje obnove odobrenja: 13. ožujka 2006.
English: Your doctor will do regular blood tests to check for any changes in:
Croatian: Liječnik će Vas redovito slati na krvne pretrage kako bi provjerio eventualne promjene u:
English: Your doctor or nurse will make up the medicine and give it to you.
Croatian: Vaš liječnik ili medicinska sestra će pripremiti lijek i dati Vam ga.
English: Preparation of suspension
Croatian: Priprema suspenzije
English: Do not take any capsules that have broken open or split.
Croatian: • Ne uzimajte kapsule koje su razlomljene ili odvojene.
English: If you are planning to have a child, talk to your doctor about the potential risks and alternative therapies.
Croatian: Ako planirate imati dijete, razgovarajte sa svojim liječnikom o mogućim rizicima i drugim terapijskim mogućnostima.
English: Try not to inhale the dry powder.
Croatian: Nastojte ne udahnuti suhi prašak.
English: When you are able to swallow, you will be given this medicine by mouth.
Croatian: • Čim budete mogli gutati, dobit ćete ovaj lijek kroz usta.
English: Effects of hepatic disease on this process probably depend on the particular disease.
Croatian: Utjecaj bolesti jetre na taj proces vjerojatno ovisi o pojedinoj bolesti.
English: Do not break or crush them.
Croatian: • Nemojte ih lomiti ili drobiti
English: Children (aged 2 to 18 years)
Croatian: Djeca (od 2 do 18 godina)
English: You will have the medicine for at least 4 days.
Croatian: • Lijek ćete primati barem iduća 4 dana.
English: CellCept reduces your body's defences.
Croatian: CellCept oslabljuje obranu Vašeg tijela.
English: This includes medicines obtained without a prescription, such as herbal medicines.
Croatian: To uključuje lijekove koji se mogu nabaviti bez recepta, kao što su biljni lijekovi.
English: (50 tablets)
Croatian: (50 tableta)
English: However, at high MPAG plasma concentrations (> 100µg/mL), small amounts of MPAG are removed.
Croatian: Međutim, pri visokim koncentracijama MPAG-a u plazmi (> 100µg/ml) uklonjene su male količine MPAG-a.
English: Your pharmacist will normally make up the medicine for you.
Croatian: Lijek će za Vas obično pripremiti Vaš ljekarnik.
English: Do not take a double dose to make up for a missed dose.
Croatian: Nemojte uzeti dvostruku dozu da biste nadoknadili propuštenu dozu.
English: In addition, there have been isolated reports of the following malformations:
Croatian: Osim toga, prijavljeni su i izolirani slučajevi sljedećih malformacija:
English: Keep pulling it out until the desired amount of medicine is in the dispenser.
Croatian: • Nastavite izvlačiti sve dok željena količina lijeka ne uđe u dozator.
English: If you need to do it yourself, see Section 7 “Making up the medicine”
Croatian: Ako ga morate pripremiti sami, pročitajte dio 7 „Priprema lijeka“.
English: If a dose of CellCept is missed, this will be given to you as soon as possible.
Croatian: Ako je propuštena doza lijeka CellCept, primit ćete je što je prije moguće.
English: This medicinal product contains sorbitol.
Croatian: Ovaj medicinski proizvod sadrži sorbitol.
English: Taking food and drink has no effect on your treatment with CellCept.
Croatian: Uzimanje hrane i pića ne utječe na Vaše liječenje lijekom CellCept.
English: Your treatment will then continue at the normal times.
Croatian: Daljnje liječenje će se nastaviti u uobičajenim terminima.
English: Skin problems such as:
Croatian: Probleme s kožom kao što su:
English: It is available in packs of 4 vials.
Croatian: • Dostupan je u pakiranjima od 4 bočice.
English: Do not use the suspension past this expiry date.
Croatian: Nemojte koristiti suspenziju nakon tog datuma roka valjanosti.
English: Your doctor will have to advise you on which vaccines you can have.
Croatian: Liječnik će Vas savjetovati o tome koja cjepiva možete primiti.
English: For 6 weeks after you stop taking CellCept.
Croatian: • razdoblje od 6 tjedana nakon što prestanete uzimati CellCept.
English: If you are planning to become pregnant or if you get pregnant while you or your partner are taking CellCept.
Croatian: • ako planirate trudnoću ili ako zatrudnite dok Vi ili Vaš partner uzimate CellCept
English: If you feel drowsy, numb or confused, talk to your doctor or nurse and do not drive or use any tools or machines until you feel better.
Croatian: Ako se osjećate omamljeno, utrnulo ili smeteno, obratite se svom liječniku ili medicinskoj sestri i nemojte upravljati vozilima ni koristiti nikakve alate ili strojeve dok se ne budete osjećali bolje.
English: • Medicines should not be disposed of via wastewater or household waste.
Croatian: • Lijekovi se ne smiju uklanjati putem otpadnih voda ili kućnog otpada.
English: This will be given as 1 g in the morning and then 1 g in the evening.
Croatian: • To ćete dobiti kao 1 g ujutro i 1 g navečer.
English: Turn the whole thing upside down (bottle and dispenser - see picture below).
Croatian: 5. Sve zajedno (bocu i dozator) preokrenite (vidjeti sliku u nastavku).
English: There have also been reports of bronchiectasis in children and adults.
Croatian: Također su zabilježeni slučajevi bronhiektazija kod djece i odraslih.
English: CellCept contains sorbitol (a type of sugar).
Croatian: • CellCept sadrži sorbitol (jednu vrstu šećera).
English: Other in vitro tests for detection of gene mutation did not demonstrate genotoxic activity.
Croatian: Ostali in vitro testovi za otkrivanje mutacije gena nisu pokazali genotoksičnu aktivnost.
English: These effects can be related to the pharmacodynamic mode of action, i.e. inhibition of nucleotide synthesis in sensitive cells.
Croatian: Ti učinci mogu biti povezani s farmakodinamičkim načinom djelovanja, odnosno inhibicijom sinteze nukleotida u osjetljivim stanicama.
English: In this leaflet the shorter name CellCept is used.
Croatian: • U ovoj uputi koristi se skraćeno ime CellCept.
English: Add about half of the total amount of purified water to the bottle.
Croatian: Dodajte približno polovicu ukupne količine pročišćene vode u bocu.
English: Infections and infestations Bacterial infections
Croatian: Infekcije i infestacije Bakterijske infekcije
English: Step 2 a.
Croatian: 2. korak a.
English: This is because CellCept can affect the way some other medicines work.
Croatian: To je zato što CellCept može utjecati na način djelovanja drugih lijekova.
English: Pharmacotherapeutic group: immunosuppressive agents ATC code L04AA06
Croatian: Farmakoterapijska skupina: imunosupresivi, ATK oznaka: L04AA06
English: If you are a woman who could become pregnant you must use an effective method of contraception with CellCept.
Croatian: Ako ste žena koja bi mogla zatrudnjeti, uz CellCept morate koristiti učinkovitu metodu kontracepcije.
English: • telmisartan - used to treat high blood pressure
Croatian: • telmisartan - koristi se za liječenje visokog krvnog tlaka
English: What CellCept is and what it is used for
Croatian: Što je CellCept i za što se koristi
English: Step 1 a.
Croatian: 1. korak a.
English: The proportion of patients with CMV viraemia/syndrome was 13.5%.
Croatian: Udio bolesnika oboljelih od CMV viremije/sindroma iznosio je 13,5%.
English: • rifampicin - an antibiotic used to prevent and treat infections such as tuberculosis (TB)
Croatian: • rifampicin - antibiotik koji se koristi za prevenciju i liječenje infekcija kao što je tuberkuloza
English: (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000)
Croatian: (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000) i vrlo rijetko (< 1/10 000).
English: Preparation of Infusion Solution (6 mg/mL)
Croatian: Priprema infuzijske otopine (6 mg/ml)
English: It is recommended, however, to administer CellCept at least one hour before or three hours after sevelamer intake to minimise the impact on the absorption of MPA.
Croatian: Preporučuje se, međutim, primjena lijeka CellCept barem jedan sat prije odnosno tri sata nakon uzimanja sevelamera da bi se umanjio utjecaj na apsorpciju MPA.
English: Pull the plunger out slowly.
Croatian: Lagano izvucite klip
English: The bottle adapter should stay in the bottle.
Croatian: Nastavak za bocu treba ostati na boci.
English: This belongs to a group of medicines called “immunosuppressants”.
Croatian: • Pripada skupini lijekova koji se nazivaju ”imunosupresivi”.
English: As some adverse reactions occur with greater frequency in this age group (see section 4.8) compared with adults, temporary dose reduction or interruption may be required; these will need to take into account relevant clinical factors including severity of reaction.
Croatian: Budući da su neke nuspojave u ovoj dobnoj skupini (vidjeti dio 4.8) češće nego u odraslih, možda će biti potrebno privremeno smanjiti dozu ili prekinuti liječenje, za što treba uzeti u obzir relevantne kliničke faktore, uključujući težinu reakcije.
English: Psychiatric disorders Confusional state
Croatian: Psihijatrijski poremećaji Konfuzno stanje
English: Also other medicines can affect the way CellCept works.
Croatian: Također, drugi lijekovi mogu utjecati na način djelovanja lijeka CellCept.
English: It is given as a slow drip (infusion) into a vein.
Croatian: On se daje u obliku sporog dripa (infuzija) u venu.
English: Wearing disposable gloves is recommended during reconstitution and when wiping the outer surface of the bottle/cap and the table after reconstitution.
Croatian: Preporučuje se nošenje jednokratnih rukavica tijekom rekonstitucije lijeka i prilikom brisanja vanjske površine boce/zatvarača i stola nakon rekonstitucije.
English: In those overdose cases in which adverse events were reported, the events fall within the known safety profile of the medicinal product.
Croatian: U onim slučajevima predoziranja u kojima su zabilježeni štetni događaji, profil tih događaja odgovara sigurnosnom profilu lijeka.
English: Cellcept may cause somnolence, confusion, dizziness, tremor or hypotension, and therefore patients are advised to use caution when driving or using machines.
Croatian: Cellcept može uzrokovati somnolenciju, konfuziju, omaglicu, tremor ili hipotenziju, pa se bolesnicima preporučuje oprez prilikom upravljanja vozilima ili rada sa strojevima.